CME Financial Statements From 2010 to 2024

CME Stock  USD 215.60  2.72  1.28%   
CME financial statements provide useful quarterly and yearly information to potential CME Group investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on CME financial statements helps investors assess CME's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CME's valuation are summarized below:
Gross Profit
B
Profit Margin
0.5793
Market Capitalization
77.6 B
Enterprise Value Revenue
13.9855
Revenue
5.6 B
There are over one hundred nineteen available fundamental signals for CME Group, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of CME's prevailing performance against the performance from 2010 to 2024 to make sure the company is sustainable in the future.
Check CME financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CME main balance sheet or income statement drivers, such as Depreciation And Amortization of 370.2 M, Interest Expense of 107.7 M or Selling And Marketing Expenses of 171 M, as well as many exotic indicators such as Short Term Coverage Ratios of 59.23, Price Earnings Ratio of 13.02 or Price To Sales Ratio of 8.04. CME financial statements analysis is a perfect complement when working with CME Valuation or Volatility modules.
  
This module can also supplement CME's financial leverage analysis and stock options assessment as well as various CME Technical models . Check out the analysis of CME Correlation against competitors.

CME Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets136.3 B129.8 B88.9 B
Slightly volatile
Short and Long Term Debt Total2.4 B3.9 B2.8 B
Slightly volatile
Other Current Liabilities98 B93.3 B56.8 B
Slightly volatile
Total Current Liabilities98.1 B93.4 B57.4 B
Slightly volatile
Total Stockholder Equity17.6 B26.7 B21.7 B
Slightly volatile
Other Liabilities6.2 B6.6 BB
Pretty Stable
Property Plant And Equipment Net483.4 M681.5 M510.9 M
Very volatile
Retained EarningsB4.5 B3.8 B
Slightly volatile
Accounts Payable51.7 M90.6 M53.6 M
Slightly volatile
Cash3.1 B2.9 B1.9 B
Slightly volatile
Non Current Assets Total24 B34.8 B29.5 B
Slightly volatile
Other Assets127.7 M134.4 M3.8 B
Slightly volatile
Long Term Debt2.5 B3.4 B2.5 B
Slightly volatile
Cash And Short Term Investments2.7 BB2.5 B
Pretty Stable
Net Receivables1.3 B1.3 B486.6 M
Slightly volatile
Common Stock Total Equity4.3 M4.1 M3.2 M
Slightly volatile
Common Stock Shares Outstanding311.9 M359.5 M329.8 M
Slightly volatile
Liabilities And Stockholders Equity136.3 B129.8 B88.9 B
Slightly volatile
Non Current Liabilities Total7.4 B9.6 B8.9 B
Slightly volatile
Other Stockholder Equity14.5 B22.3 B17.8 B
Slightly volatile
Total Liabilities108.3 B103.1 B66.5 B
Slightly volatile
Property Plant And Equipment Gross1.4 B1.3 B616.7 M
Slightly volatile
Total Current Assets99.6 B94.9 B58.5 B
Slightly volatile
Common Stock2.2 M4.1 MM
Slightly volatile
Property Plant Equipment490.1 M963.2 M555.6 M
Slightly volatile
Short Term Investments106.1 M111.7 M822.8 M
Slightly volatile
Short Term Debt52.3 M55.1 M10.8 B
Pretty Stable
Intangible Assets18.4 B20.2 B18.8 B
Slightly volatile
Good Will8.9 B10.5 B8.4 B
Slightly volatile
Long Term Debt Total2.9 B3.1 B2.6 B
Slightly volatile
Capital Surpluse20.8 B25.5 B19.6 B
Slightly volatile
Non Current Liabilities Other698.7 M798.2 M627 M
Slightly volatile
Long Term Investments1.2 B1.2 B669.7 M
Slightly volatile
Short and Long Term Debt13.7 M14.4 M5.6 B
Very volatile
Net Invested Capital20.5 B30.2 B24.8 B
Pretty Stable
Net Working Capital1.3 B1.5 B1.2 B
Pretty Stable
Capital Stock2.9 M3.2 M3.5 M
Slightly volatile

CME Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization370.2 M352.6 M158.3 M
Slightly volatile
Selling And Marketing Expenses171 M162.9 M135.9 M
Slightly volatile
Total RevenueB5.6 B3.7 B
Slightly volatile
Gross Profit2.5 B4.5 BB
Slightly volatile
Other Operating Expenses1.3 B2.1 B1.5 B
Slightly volatile
EBITDA1.9 B3.8 B2.3 B
Slightly volatile
Total Operating Expenses734.7 M1.1 B884.9 M
Slightly volatile
Selling General Administrative265.9 M144.4 M282.6 M
Slightly volatile
Cost Of Revenue557.7 MB650.4 M
Slightly volatile
Net Income Applicable To Common Shares3.2 B3.1 BB
Slightly volatile
Net Income From Continuing Ops2.4 BB2.2 B
Slightly volatile
Non Operating Income Net Other1.1 BB388.8 M
Slightly volatile
Interest Income453.2 M732.2 M347.3 M
Slightly volatile
Reconciled Depreciation392.8 M356.9 M290.1 M
Slightly volatile

CME Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow3.5 B3.4 B1.9 B
Slightly volatile
Begin Period Cash Flow2.6 B2.7 B18 B
Slightly volatile
Depreciation238.2 M352.6 M280.4 M
Slightly volatile
Capital Expenditures127.9 M76.4 M124 M
Pretty Stable
Total Cash From Operating Activities3.6 B3.5 BB
Slightly volatile
End Period Cash Flow2.8 B2.9 B21.4 B
Slightly volatile
Stock Based Compensation64.8 M82.9 M66.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Short Term Coverage Ratios59.2356.4128.1911
Pretty Stable
Price To Sales Ratio8.0413.552910.8131
Slightly volatile
Dividend Yield0.02370.04280.036
Very volatile
Operating Cycle77.7281.814121.8 K
Slightly volatile
Price Book Value Ratio3.82.82782.4597
Very volatile
Days Of Payables Outstanding30.2531.84343.5877
Slightly volatile
Operating Cash Flow Per Share10.19.625.8554
Slightly volatile
Dividend Payout Ratio0.561.00290.8467
Pretty Stable
Price To Operating Cash Flows Ratio17.921.891923.1391
Very volatile
Free Cash Flow Per Share9.889.40725.5026
Slightly volatile
Price To Free Cash Flows Ratio28.9922.387126.6041
Very volatile
Inventory Turnover0.00610.00640.2342
Slightly volatile
Ebt Per Ebit0.811.2091.0377
Slightly volatile
Payables Turnover8.7711.462513.654
Pretty Stable
Company Equity Multiplier4.284.8563.7018
Slightly volatile
Long Term Debt To Capitalization0.07270.11360.0962
Slightly volatile
Cash Per Share10.098.43657.5783
Pretty Stable
Total Debt To Capitalization0.160.11520.2604
Pretty Stable
Payout Ratio0.561.00290.8467
Pretty Stable
Debt Equity Ratio0.120.13020.6173
Pretty Stable
Quick Ratio0.04350.04580.1508
Slightly volatile
Net Income Per E B T0.560.77670.7677
Very volatile
Cash Ratio0.02970.03120.0626
Slightly volatile
Operating Cash Flow Sales Ratio0.360.61910.4689
Slightly volatile
Days Of Inventory Outstanding61.9 K59 K30.1 K
Slightly volatile
Days Of Sales Outstanding85.981.814143.7637
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.690.97790.894
Pretty Stable
Cash Flow Coverage Ratios0.940.99230.8439
Pretty Stable
Price To Book Ratio3.82.82782.4597
Very volatile
Current Ratio1.221.01581.0731
Slightly volatile
Fixed Asset Turnover5.028.18627.1668
Slightly volatile
Price Cash Flow Ratio17.921.891923.1391
Very volatile
Enterprise Value Multiple14.820.214120.5346
Very volatile
Debt Ratio0.02550.02680.1837
Pretty Stable
Cash Flow To Debt Ratio0.940.99230.8439
Pretty Stable
Price Sales Ratio8.0413.552910.8131
Slightly volatile
Receivables Turnover4.244.46139.0966
Slightly volatile
Asset Turnover0.04080.0430.0861
Slightly volatile
Gross Profit Margin0.920.81390.8356
Pretty Stable
Price Fair Value3.82.82782.4597
Very volatile

CME Fundamental Market Drivers

Forward Price Earnings22.5225
Cash And Short Term InvestmentsB

CME Upcoming Events

14th of February 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About CME Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include CME income statement, its balance sheet, and the statement of cash flows. CME investors use historical funamental indicators, such as CME's revenue or net income, to determine how well the company is positioned to perform in the future. Although CME investors may use each financial statement separately, they are all related. The changes in CME's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CME's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on CME Financial Statements. Understanding these patterns can help to make the right decision on long term investment in CME. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue-55.1 M-57.9 M
Total Revenue5.6 BB
Cost Of RevenueB557.7 M
Ebit Per Revenue 0.62  0.42 

Pair Trading with CME

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CME position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CME will appreciate offsetting losses from the drop in the long position's value.

Moving together with CME Stock

  0.81MORN MorningstarPairCorr

Moving against CME Stock

  0.67DHIL Diamond Hill InvestmentPairCorr
  0.63MCBC Macatawa Bank Fiscal Quarter End 31st of March 2024 PairCorr
  0.61MBCN Middlefield Banc Fiscal Quarter End 31st of March 2024 PairCorr
  0.56VALU Value LinePairCorr
  0.51SPGI SP Global Financial Report 25th of April 2024 PairCorr
The ability to find closely correlated positions to CME could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CME when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CME - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CME Group to buy it.
The correlation of CME is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CME moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CME Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CME can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out the analysis of CME Correlation against competitors.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for CME Stock analysis

When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.276
Dividend Share
4.4
Earnings Share
8.86
Revenue Per Share
15.512
Quarterly Revenue Growth
0.192
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.